Pick Topic
Review Topic
List Experts
Examine Expert
Save Expert
  Site Guide ··   
Expertise in Migraine Disorders: HELP
Amynah A. A. Pradhan
Based on 6 articles published since 2008
||||
Expertise Level
The expertise of Amynah A. A. Pradhan ranks in the
  • Top 2.1%
  • ... of 22,618 published authors worldwide on Migraine Disorders
  • ... from 2008 through 2019
  • ... based on contributions to 6 articles on the topic.
Graphical view (beta)
Uncounted papers?
Aliases Pradhan, Amynah A A   ·   Pradhan, Amynah A
Work Locations
Details
Most likely:    University of Illinois Chicago   Contact    
2018
  • Department of Psychiatry, University of Illinois at Chicago, 1601 W Taylor Street (MC 912), Chicago, IL, 60612, USA. · Department of Psychiatry, University of Illinois at Chicago, 1601 W Taylor Street (MC 912), Chicago, IL, 60612, USA. · Department of Neural and Pain Sciences, University of Maryland Baltimore, 650 W. Baltimore Street, Baltimore, MD, 21201, USA. · Pubmed 29516436
2017
  • Department of Psychiatry, University of Illinois at Chicago, Chicago, Illinois. · Pubmed 28678396
2016
  • 1 Department of Psychiatry, University of Illinois at Chicago, USA. · 2 Headache Research and Treatment Program, Department of Neurology, David Geffen School of Medicine, UCLA, USA. · Pubmed 26682574
2014
  • Semel Institute for Neuropsychiatry & Human Behavior, University of California, Los Angeles (UCLA), Los Angeles, CA, USA; Headache Research and Treatment Program, Department of Neurology David Geffen School of Medicine, UCLA, Los Angeles, CA, USA; Shirley and Stefan Hatos Center for Neuropharmacology, UCLA, Los Angeles, CA, USA; Department of Psychiatry, University of Illinois at Chicago (UIC), Chicago, IL, USA. · Pubmed 24467301
  • Semel Institute for Neuropsychiatry and Human Behavior, University of California, Los Angeles, USA; Shirley and Stefan Hatos Center for Neuropharmacology, University of California, Los Angeles, USA; Headache Research and Treatment Program, Department of Neurology, David Geffen School of Medicine, University of California, Los Angeles, USA; Department of Psychiatry, University of Illinois at Chicago, USA. Electronic address: · Semel Institute for Neuropsychiatry and Human Behavior, University of California, Los Angeles, USA; Shirley and Stefan Hatos Center for Neuropharmacology, University of California, Los Angeles, USA; Headache Research and Treatment Program, Department of Neurology, David Geffen School of Medicine, University of California, Los Angeles, USA. · Shirley and Stefan Hatos Center for Neuropharmacology, University of California, Los Angeles, USA; Headache Research and Treatment Program, Department of Neurology, David Geffen School of Medicine, University of California, Los Angeles, USA. · Semel Institute for Neuropsychiatry and Human Behavior, University of California, Los Angeles, USA; Shirley and Stefan Hatos Center for Neuropharmacology, University of California, Los Angeles, USA. · Pubmed 24121068
2016
  • aUCLA Goldberg Migraine Program, David Geffen School of Medicine at UCLA, Los Angeles, California bDepartment of Psychiatry, University of Illinois at Chicago, Chicago, Illinois, USA. · Pubmed 27023737
Probable:    UCLA   Contact    
2014
  • Semel Institute for Neuropsychiatry & Human Behavior, University of California, Los Angeles (UCLA), Los Angeles, CA, USA; Headache Research and Treatment Program, Department of Neurology David Geffen School of Medicine, UCLA, Los Angeles, CA, USA; Shirley and Stefan Hatos Center for Neuropharmacology, UCLA, Los Angeles, CA, USA; Department of Psychiatry, University of Illinois at Chicago (UIC), Chicago, IL, USA. · Pubmed 24467301
  • Semel Institute for Neuropsychiatry and Human Behavior, University of California, Los Angeles, USA; Shirley and Stefan Hatos Center for Neuropharmacology, University of California, Los Angeles, USA; Headache Research and Treatment Program, Department of Neurology, David Geffen School of Medicine, University of California, Los Angeles, USA; Department of Psychiatry, University of Illinois at Chicago, USA. Electronic address: · Semel Institute for Neuropsychiatry and Human Behavior, University of California, Los Angeles, USA; Shirley and Stefan Hatos Center for Neuropharmacology, University of California, Los Angeles, USA; Headache Research and Treatment Program, Department of Neurology, David Geffen School of Medicine, University of California, Los Angeles, USA. · Shirley and Stefan Hatos Center for Neuropharmacology, University of California, Los Angeles, USA; Headache Research and Treatment Program, Department of Neurology, David Geffen School of Medicine, University of California, Los Angeles, USA. · Semel Institute for Neuropsychiatry and Human Behavior, University of California, Los Angeles, USA; Shirley and Stefan Hatos Center for Neuropharmacology, University of California, Los Angeles, USA. · Pubmed 24121068
2016
  • aUCLA Goldberg Migraine Program, David Geffen School of Medicine at UCLA, Los Angeles, California bDepartment of Psychiatry, University of Illinois at Chicago, Chicago, Illinois, USA. · Pubmed 27023737
Specific Interests

In the titles of their published articles, experts often reveal their very specific interests.

Here are the titles of all articles written by Amynah A. A. Pradhan in 2008-2019 about Migraine Disorders:

  • Targeted Nitric Oxide Synthase Inhibitors for Migraine. 2018
  • Animal Model of Chronic Migraine-Associated Pain. 2017
  • Delta-opioid receptors as targets for migraine therapy. 2016
  • The effects of acute and preventive migraine therapies in a mouse model of chronic migraine. 2016
  • δ-Opioid receptor agonists inhibit migraine-related hyperalgesia, aversive state and cortical spreading depression in mice. 2014
  • Characterization of a novel model of chronic migraine. 2014
Show List of Full Article Records
Google Searches

Learn more about Amynah A. A. Pradhan using the ready-made Google searches below.
This is essential! -- Publications never tell the whole story!

General Search:
University of Illinois Chicago
UCLA
Affiliation Timeline
Click for institutional directory in table below. (Not always available.)
What is this?
University of Illinois Chicago
2018
  • Department of Psychiatry, University of Illinois at Chicago, 1601 W Taylor Street (MC 912), Chicago, IL, 60612, USA. · Department of Psychiatry, University of Illinois at Chicago, 1601 W Taylor Street (MC 912), Chicago, IL, 60612, USA. · Department of Neural and Pain Sciences, University of Maryland Baltimore, 650 W. Baltimore Street, Baltimore, MD, 21201, USA. · Pubmed 29516436
2017
  • Department of Psychiatry, University of Illinois at Chicago, Chicago, Illinois. · Pubmed 28678396
2016
  • 1 Department of Psychiatry, University of Illinois at Chicago, USA. · 2 Headache Research and Treatment Program, Department of Neurology, David Geffen School of Medicine, UCLA, USA. · Pubmed 26682574
2014
  • Semel Institute for Neuropsychiatry & Human Behavior, University of California, Los Angeles (UCLA), Los Angeles, CA, USA; Headache Research and Treatment Program, Department of Neurology David Geffen School of Medicine, UCLA, Los Angeles, CA, USA; Shirley and Stefan Hatos Center for Neuropharmacology, UCLA, Los Angeles, CA, USA; Department of Psychiatry, University of Illinois at Chicago (UIC), Chicago, IL, USA. · Pubmed 24467301
  • Semel Institute for Neuropsychiatry and Human Behavior, University of California, Los Angeles, USA; Shirley and Stefan Hatos Center for Neuropharmacology, University of California, Los Angeles, USA; Headache Research and Treatment Program, Department of Neurology, David Geffen School of Medicine, University of California, Los Angeles, USA; Department of Psychiatry, University of Illinois at Chicago, USA. Electronic address: · Semel Institute for Neuropsychiatry and Human Behavior, University of California, Los Angeles, USA; Shirley and Stefan Hatos Center for Neuropharmacology, University of California, Los Angeles, USA; Headache Research and Treatment Program, Department of Neurology, David Geffen School of Medicine, University of California, Los Angeles, USA. · Shirley and Stefan Hatos Center for Neuropharmacology, University of California, Los Angeles, USA; Headache Research and Treatment Program, Department of Neurology, David Geffen School of Medicine, University of California, Los Angeles, USA. · Semel Institute for Neuropsychiatry and Human Behavior, University of California, Los Angeles, USA; Shirley and Stefan Hatos Center for Neuropharmacology, University of California, Los Angeles, USA. · Pubmed 24121068
2016
  • aUCLA Goldberg Migraine Program, David Geffen School of Medicine at UCLA, Los Angeles, California bDepartment of Psychiatry, University of Illinois at Chicago, Chicago, Illinois, USA. · Pubmed 27023737
UCLA
2014
  • Semel Institute for Neuropsychiatry & Human Behavior, University of California, Los Angeles (UCLA), Los Angeles, CA, USA; Headache Research and Treatment Program, Department of Neurology David Geffen School of Medicine, UCLA, Los Angeles, CA, USA; Shirley and Stefan Hatos Center for Neuropharmacology, UCLA, Los Angeles, CA, USA; Department of Psychiatry, University of Illinois at Chicago (UIC), Chicago, IL, USA. · Pubmed 24467301
  • Semel Institute for Neuropsychiatry and Human Behavior, University of California, Los Angeles, USA; Shirley and Stefan Hatos Center for Neuropharmacology, University of California, Los Angeles, USA; Headache Research and Treatment Program, Department of Neurology, David Geffen School of Medicine, University of California, Los Angeles, USA; Department of Psychiatry, University of Illinois at Chicago, USA. Electronic address: · Semel Institute for Neuropsychiatry and Human Behavior, University of California, Los Angeles, USA; Shirley and Stefan Hatos Center for Neuropharmacology, University of California, Los Angeles, USA; Headache Research and Treatment Program, Department of Neurology, David Geffen School of Medicine, University of California, Los Angeles, USA. · Shirley and Stefan Hatos Center for Neuropharmacology, University of California, Los Angeles, USA; Headache Research and Treatment Program, Department of Neurology, David Geffen School of Medicine, University of California, Los Angeles, USA. · Semel Institute for Neuropsychiatry and Human Behavior, University of California, Los Angeles, USA; Shirley and Stefan Hatos Center for Neuropharmacology, University of California, Los Angeles, USA. · Pubmed 24121068
2016
  • aUCLA Goldberg Migraine Program, David Geffen School of Medicine at UCLA, Los Angeles, California bDepartment of Psychiatry, University of Illinois at Chicago, Chicago, Illinois, USA. · Pubmed 27023737
Yearly article counts 011202000000
Remember this Person You can save this page -- like a bookmark -- so it's remembered for you on the Expertscape "Saved Pages" page, which is always easily available from the page-top menu bar throughout the site.